Literature DB >> 8413944

Auditory function in Alzheimer's disease.

D D Kurylo1, S Corkin, T Allard, R J Zatorre, J H Growdon.   

Abstract

The pattern of cerebral degeneration in Alzheimer's disease (AD) patients suggests that basic auditory capacities should be normal in AD, whereas progressively higher levels of auditory function should be increasingly impaired. To test this hypothesis, we administered tests of auditory capacities associated with primary auditory cortex (sound localization and perception of complex tones) and auditory association cortex (phoneme discrimination, timbre discrimination, and tonal memory) to 19 mildly to moderately demented AD patients, 21 elderly control subjects (ECS), and 14 young control subjects (YCS). The results showed significant differences between YCS and ECS on phoneme discrimination with synthetic speech and on tonal memory. The AD group differed from the ECS group on sound localization, one measure of synthetic speech discrimination, and timbre discrimination. Performance did not correlate with age, dementia severity, or duration of illness on any test condition. These findings indicate that although AD is accompanied by specific auditory deficits, the increase in neuropathologic change between primary auditory and auditory association cortices is not reflected in an increased impairment of functions that are mediated by these areas. Degraded aural language comprehension, which is characteristic of AD, likely reflects disruption of language processes, rather than dysfunction specific to auditory circuits.

Entities:  

Mesh:

Year:  1993        PMID: 8413944     DOI: 10.1212/wnl.43.10.1893

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  19 in total

Review 1.  Hearing and music in dementia.

Authors:  Julene K Johnson; Maggie L Chow
Journal:  Handb Clin Neurol       Date:  2015

2.  [Impaired recognition of environmental sounds in patients with dementia : I can hear but I do not understand].

Authors:  Birgit Dietz; Sarah Kohl; Johannes Mayer; Christoph Metzger; Hans Förstl; Janine Diehl-Schmid
Journal:  Z Gerontol Geriatr       Date:  2017-05-10       Impact factor: 1.281

3.  Age-related deficits in auditory confrontation naming.

Authors:  Brenda Hanna-Pladdy; Hyun Choi
Journal:  Psychol Aging       Date:  2010-09

Review 4.  Hearing and Cognitive Impairment and the Role of the International Classification of Functioning, Disability and Health as a Rehabilitation Framework.

Authors:  Christopher Lind; Carly Meyer; Jessica Young
Journal:  Semin Hear       Date:  2016-08

Review 5.  Age-related hearing impairment-a risk factor and frailty marker for dementia and AD.

Authors:  Francesco Panza; Vincenzo Solfrizzi; Giancarlo Logroscino
Journal:  Nat Rev Neurol       Date:  2015-02-17       Impact factor: 42.937

6.  Disease specificity and pathologic progression of tau pathology in brainstem nuclei of Alzheimer's disease and progressive supranuclear palsy.

Authors:  Brittany N Dugger; Michael Tu; Melissa E Murray; Dennis W Dickson
Journal:  Neurosci Lett       Date:  2011-01-12       Impact factor: 3.046

7.  Hearing loss is an early biomarker in APP/PS1 Alzheimer's disease mice.

Authors:  Yang Liu; Shu Fang; Li-Man Liu; Yan Zhu; Chang-Ri Li; Kaitian Chen; Hong-Bo Zhao
Journal:  Neurosci Lett       Date:  2019-12-20       Impact factor: 3.046

8.  Music Perception in Dementia.

Authors:  Hannah L Golden; Camilla N Clark; Jennifer M Nicholas; Miriam H Cohen; Catherine F Slattery; Ross W Paterson; Alexander J M Foulkes; Jonathan M Schott; Catherine J Mummery; Sebastian J Crutch; Jason D Warren
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

9.  Auditory object cognition in dementia.

Authors:  Johanna C Goll; Lois G Kim; Julia C Hailstone; Manja Lehmann; Aisling Buckley; Sebastian J Crutch; Jason D Warren
Journal:  Neuropsychologia       Date:  2011-06-13       Impact factor: 3.139

10.  Impaired cross-modal inhibition in Alzheimer disease.

Authors:  Alexander Drzezga; Timo Grimmer; Martin Peller; Marc Wermke; Hartwig Siebner; Josef P Rauschecker; Markus Schwaiger; Alexander Kurz
Journal:  PLoS Med       Date:  2005-09-20       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.